Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long Non-Coding RNAs Identified as Hub Genes by Weighted Gene Co-Expression Network Analysis in <i>Schistosoma mansoni</i> Following Incubation with <i>Bothrops</i> Snake Venoms.

International journal of molecular sciences·2026
Same author

Proteomic profiling reveals region-specific neuroimmune and apoptotic signatures induced by Bothrops jararaca venom toxins in the murine brain.

Biochimie·2026
Same author

A Degradomic Landscape of Proteolytic Remodeling in Melanoma Lung Metastasis.

Journal of proteome research·2026
Same author

Combining information on degradomics and gene expression data in prospecting metastatic melanoma proteolytic signatures.

Journal of proteomics·2026
Same author

Assessing systemic effects of Bothrops jararaca venom in the lungs in a mouse model by label-free proteomics using DDA and DIA.

Journal of proteomics·2025
Same author

<i>N</i>-Glycoproteomic Portraits of <i>Bothrops</i> Snake Venoms Reveal Evolutionarily Conserved and Divergent Phenotypes.

Journal of proteome research·2025

Related Experiment Video

Updated: May 30, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Bradykinin-potentiating peptides: beyond captopril.

Antonio C M Camargo1, Danielle Ianzer, Juliano R Guerreiro

  • 1Department of Cell Biology and Development, Institute of Biomedical Sciences, University of São Paulo, Brazil. acmcamargo@butantan.gov.br

Toxicon : Official Journal of the International Society on Toxinology
|August 13, 2011
PubMed
Summary

Snake peptides offer new avenues for hypertension treatment. Research shows a specific peptide activates argininosuccinate synthetase, boosting nitric oxide production to lower blood pressure.

More Related Videos

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

Related Experiment Videos

Last Updated: May 30, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Research

Background:

  • Vascular tonus regulation involves complex endogenous and exogenous molecules.
  • Bradykinin and bradykinin-potentiating peptides, discovered from Bothrops jararaca envenoming, significantly advanced cardiovascular pathophysiology understanding and hypertension drug development (e.g., captopril).

Purpose of the Study:

  • To explore snake proline-rich oligopeptides (bradykinin-potentiating peptides) as a source of novel drug development leads and therapeutic targets.
  • To investigate the specific function of Bj-BPP-10c, a bradykinin-potentiating peptide from B. jararaca.

Main Methods:

  • The study focused on identifying and characterizing the functional targets of bradykinin-potentiating peptides from snake venom.
  • Specific emphasis was placed on evaluating the effect of Bj-BPP-10c on argininosuccinate synthetase activity and subsequent nitric oxide production.

Main Results:

  • Argininosuccinate synthetase was identified as a novel functional target for the snake peptide Bj-BPP-10c.
  • Bj-BPP-10c activates argininosuccinate synthetase, leading to increased nitric oxide (NO) production.
  • Elevated NO levels contribute to reduced arterial blood pressure.

Conclusions:

  • Snake bradykinin-potentiating peptides remain a valuable resource for scientific discovery in drug development.
  • Bj-BPP-10c presents a promising lead molecule and highlights argininosuccinate synthetase as a potential new target for managing hypertension through enhanced nitric oxide signaling.